(Q42958598)

11 November 2017

title

Therapy: Low-dose flutamide for hirsutism: into the limelight, at last (English)

1 reference

11 November 2017

1 reference

Francis de Zegher

1

1 reference

11 November 2017

Lourdes Ibáñez

series ordinal

2

1 reference

11 November 2017

publication date

1 August 2010

1 reference

Nature Reviews Endocrinology

11 November 2017

published in

1 reference

11 November 2017

volume

6

1 reference

11 November 2017

issue

8

1 reference

11 November 2017

page(s)

421-422

1 reference

Retrospective observational study on the effects and tolerability of flutamide in a large population of patients with various kinds of hirsutism over a 15-year period

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.119

31 March 2020

Flutamide Hepatotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.119

Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.119

Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.119

Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.119

Long-Term Efficacy and Tolerability of Flutamide Combined with Oral Contraception in Moderate to Severe Hirsutism: A 12-Month, Double-Blind, Parallel Clinical Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.119

Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.119

Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.119

Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.119

Flutamide for androgen excess: low dose is best

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.119

31 March 2020

Identifiers

DOI

10.1038/NRENDO.2010.119

1 reference

Dimensions Publication ID

11 November 2017

1005058391

0 references

1 reference